+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

U

Actively Recruiting

Researchers are studying whether ultrasound-guided alcohol sclerotherapy can reduce pelvic pain and improve quality of life in women aged 18 to 45 diagnosed with ovarian endometriomas, compared to expectant management. Endometriosis is a common condition causing chronic pelvic pain and fertility issues, with ovarian endometrioma being the most frequent form. This trial aims to clarify if sclerotherapy offers better symptom relief and quality of life improvements than simply monitoring the condition. Participants will be randomly assigned to either receive ultrasound-guided alcohol sclerotherapy, where the cyst is punctured and treated with alcohol for 15 minutes followed by a wash, or to a control group receiving expectant management with standard pain care if needed. The study will compare these groups over 6 months, focusing on pain levels, quality of life, and fertility outcomes. During the study, participants will complete pain and quality of life assessments at the start and after 6 months. They will also provide blood and urine samples for biomarker analysis and undergo tests to assess ovarian reserve. Researchers will monitor adverse events, recurrence, pregnancy rates over about 2 years, and healthcare costs. The study uses rigorous analysis methods to assess the benefits and risks of the treatment.

Age: 18Years - 45YearsFEMALEPhase Not Applicable
27 locations
S

Actively Recruiting

Healthy Volunteer

Researchers are investigating whether higher blood lactate levels in people with metabolic syndrome contribute to their reduced fat breakdown and glucose tolerance. The study compares metabolically healthy individuals to those with metabolic syndrome, focusing on how elevated lactate affects carbohydrate and fat metabolism at rest, during exercise, and after an oral glucose load. This research uses advanced metabolic assessments to better understand lactates role beyond being a simple by-product. The study involves two groups metabolically healthy participants who receive either an intravenous sodium lactate infusion to raise blood lactate to levels seen in metabolic syndrome or a saline infusion as a control, and metabolic syndrome participants who receive only the saline infusion. Each trial includes a 150-minute resting period, an exercise session, and a 2-hour oral glucose tolerance test. Researchers measure insulin sensitivity, fat and carbohydrate oxidation, and use stable isotopes to track metabolism. Participants undergo blood sampling to assess hormones, metabolites, and cytokines. The study measures lipolysis rate and glucose tolerance changes when blood lactate is elevated, along with secondary outcomes like insulin sensitivity and various metabolic markers. The trial lasts for an average of two years, during which detailed metabolic data are collected to understand how lactate influences metabolic processes in different states.

Age: 18Years - 65YearsAll GendersPhase Not Applicable
1 location